Scripps Whittier Diabetes Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Scripps Whittier Diabetes Institute sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
Scripps Whittier Diabetes Institute: 17 sponsored US clinical trials, 4 recruiting.
Scripps Whittier Diabetes Institute sponsors 17 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 12 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diabetes Mellitus, Type 2, with 3 trials.
Top-decile sponsor footprint
Scripps Whittier Diabetes Institute ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
NCT06296550
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
NCT05416060
Project Dulce for Arab Americans With Type 2 Diabetes
NCT05580536
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes
NCT04933851
Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7
NCT06501612
Project Dulce for Filipino-Americans With Type 2 Diabetes
NCT05378620
Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)
NCT05307237
Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19
NCT04591015
Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)
NCT04269655
Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes
NCT03130699
Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic
NCT03552107
Mi Puente: My Bridge to Better Cardiometabolic Health and Well-Being
NCT02723019
Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings
NCT02643797
Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign
NCT03068273
Dulce Digital-Project Dulce 2.0 Texting Study
NCT01749176
Telemedicine Retinal Screening Utilizing a Mobile Medical Unit
NCT01412905
Randomized Trial of Peer Led Education-Project Dulce
NCT01238289
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
What is open in the Scripps Whittier Diabetes Institute pipeline
4 recruiting of 17 indexed (24% open); 12 completed (71%).
Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).
Top condition: Diabetes Mellitus, Type 2 (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Scripps Whittier Diabetes Institute: open-pipeline peers nationwide
Peers matched on 17 registered trials and 24% open enrollment, not the therapeutic-area sidebar.
Scripps Whittier Diabetes Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 24% open enrollment (± trial volume)
- HALEON · 24% recruiting · 34 trials
- Oncotherapeutics · 24% recruiting · 17 trials
- The Mind Research Network · 24% recruiting · 17 trials
- Major Extremity Trauma Research Consortium · 23% recruiting · 30 trials
Related
What to do with this Scripps Whittier Diabetes Institute page
17 registered trials is a research-attention snapshot, not an endorsement of Scripps Whittier Diabetes Institute or any single study.
- 4 of Scripps Whittier Diabetes Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Diabetes Mellitus, Type 2 is the condition Scripps Whittier Diabetes Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetes Mellitus, Type 2 trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Scripps Whittier Diabetes Institute pipeline card: 17 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.